[1]曾磊,丁爱娇,江凌晓,等.广州市慢性乙型肝炎患者表面抗原水平分析[J].南方医科大学学报,2014,(07):974.
点击复制

广州市慢性乙型肝炎患者表面抗原水平分析()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2014年07期
页码:
974
栏目:
出版日期:
2014-07-15

文章信息/Info

Title:
Analysis of hepatitis B surface antigen levels in patients with chronic hepatitis B in
Guangzhou
作者:
曾磊丁爱娇江凌晓曾静林裕龙袁小澎
关键词:
慢性乙型肝炎表面抗原定量乙型肝炎病毒DNA
Keywords:
chronic hepatitis B hepatitis B virus hepatitis B surface antigen HBV DNA
摘要:
目的对广州市慢性乙型肝炎患者不同感染阶段表面抗原(HBsAg)水平进行定量检测,并结合乙型肝炎病毒DNA
(HBV-DNA)等检测结果探讨HBsAg定量在慢性乙型肝炎患者诊断和治疗监测的临床意义。方法按照美国肝病学会慢性乙
型肝炎分期规则标准将其分为免疫耐受期(IT)、e抗原阳性的慢性肝炎期(EPH)、非活动性携带期(IC)、e抗原阴性的慢性乙型
肝炎期(ENH)。将珠江医院就诊的慢性乙型肝炎患者96例按要求分期,对其血清样本进行HBsAg、HBV-DNA和ALT检测,并
对结果进行统计分析。结果广州市慢性乙型肝炎感染过程不同阶段HBsAg均值分别为:IT(4.12 log10 U/L)、EPH(4.02 log10 U/L)、
IC(2.85 log10 U/L)、ENH(3.29 log10 U/L),差异显著。IT、IC、EPH、ENH期患者HBsAg水平与HBV-DNA拷贝数的相关系数分
别是0.6828、0.5759、0.3280、0.1083,相关性逐步减弱。HBeAg(+)患者HBsAg定量水平明显高于HBeAg(-)患者。各期HBsAg
的量与ALT水平均无相关性。结论不同感染阶段的慢性乙型肝炎患者HBsAg定量水平存在差异,HBsAg水平与HBV-DNA
的不完全一致性表明HBsAg定量可以作为新的检测指标在诊断和治疗监测中发挥作用,更多的检测手段将有助于临床慢性乙
型肝炎患者的个体化分类和治疗。
Abstract:
Objective To assess the value of quantitative analysis of hepatitis B surface antigen (HBsAg) levels in the diagnosis
and therapeutic evaluations in patients with chronic hepatitis B (CHB). Methods According to the staging criteria defined by
the American Association of Liver Diseases, 96 patients with CHB admitted in Zhujiang Hospital were classified in
immune-tolerant (IT), HBeAg-positive hepatitis (EPH), inactive carrier (IC) and HBeAg-negative hepatitis (ENH) phases.
Serum HBsAg, HBV-DNA and ALT levels were quantified and their correlations were evaluated in each phase of infection.
Results The mean HBsAg titers (measured in log10U/L) differed significantly between the phases of CHB (4.12 in IT, 4.02 in
EPH, 2.85 in EPH, and 3.29 in ENH). The correlation coefficient of HBsAg with HBV-DNA was 0.6828 in IT, 0.5759 in EPH,
0.3280 in IC, and 0.1083 in ENH. Serum HBsAg titers were significantly higher in HBeAg-positive patients than in
HBeAg-negative patients. No correlation was found between HBsAg level and ALT in each phase of CHB. Conclusion The
median baseline serum HBsAg levels vary between different phases of CHB in Guangzhou, suggesting the value of HBsAg in
accurate classification of hepatitis B patients and evaluation of the therapeutic effect and outcomes of the patients.

相似文献/References:

[1]梁建新,屈杏芬,曾文铤,等. 氧化苦参碱在治疗慢性乙型肝炎中抗肝纤维化的作用机制[J].南方医科大学学报,2010,(08):1871.
 LIANG Jian-xin,QU Xing-fen,ZENG Wen-ting,et al.Mechanism of oxymatrine in preventing hepatic fibrosis formation in patients with chronic hepatitis B[J].Journal of Southern Medical University,2010,(07):1871.
[2]阎丽,王战会,杨洁,等.恩替卡韦联合阿德福韦酯对既往核苷类似物治疗失败的慢性乙肝患者疗效分析[J].南方医科大学学报,2011,(06):1009.
[3]陈建蓉,王霁,秦天强,等.复方甘草酸苷治疗慢性乙型肝炎的效果及安全性的meta分析[J].南方医科大学学报,2014,(08):1224.
[4]苏荣,罗娜,杨延斌,等.HBeAg阴性慢性乙型肝炎患者乙肝病毒基因变异和分型研究[J].南方医科大学学报,2012,(12):1804.
[5]玉艳红,原彤彤,黄力毅,等.外周血单核细胞hFgl2蛋白表达与不同临床类型肝病的关系[J].南方医科大学学报,2013,(03):436.
[6]游志毅,周福元,王雄虎,等.APOBEC3G基因多态性与慢性乙型肝炎易感性的关系[J].南方医科大学学报,2013,(05):769.
[7]刘志威,陈友鹏.阿德福韦酯导致胸痛、低磷血症2例报告[J].南方医科大学学报,2013,(09):1407.
[8]张鑫,孙学华,周振华,等.SRC同源区2结构域蛋白基因多态性与慢性乙型肝炎易感性的关系[J].南方医科大学学报,2014,(04):468.
[9]张卡,舒欣,骆海飞,等.慢性乙型肝炎患者PBMCs中ROG、GATA3和T-bet mRNA水平及其意义[J].南方医科大学学报,2016,(02):186.
[10]陈文莉,罗鸣,陈小苹,等.慢性乙型肝炎同病异证发病的分子机制:蛋白质组学分析[J].南方医科大学学报,2016,(03):410.

更新日期/Last Update: 1900-01-01